Correlation Between Bone Biologics and Talis Biomedical

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Talis Biomedical Corp, you can compare the effects of market volatilities on Bone Biologics and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Talis Biomedical.

Diversification Opportunities for Bone Biologics and Talis Biomedical

0.46

Correlation Coefficient

Bone Biologics  Talis Biomedical

Very weak diversification

The 3 months correlation between Bone and Talis is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of Bone Biologics i.e., Bone Biologics and Talis Biomedical go up and down completely randomly.

Pair Corralation between Bone Biologics and Talis Biomedical

Given the investment horizon of 90 days Bone Biologics Corp is expected to generate 0.43 times more return on investment than Talis Biomedical. However, Bone Biologics Corp is 2.32 times less risky than Talis Biomedical. It trades about 0.06 of its potential returns per unit of risk. Talis Biomedical Corp is currently generating about -0.75 per unit of risk. If you would invest  140.00  in Bone Biologics Corp on August 30, 2024 and sell it today you would lose (14.00) from holding Bone Biologics Corp or give up 10.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	7.81%
Values	Daily Returns

Bone Biologics Corp  vs.  Talis Biomedical Corp

Bone Biologics Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Talis Biomedical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Bone Biologics and Talis Biomedical

The main advantage of trading using opposite Bone Biologics and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.

The idea behind Bone Biologics Corp and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.